180 related articles for article (PubMed ID: 2186504)
1. [Preparation of vaccines].
Ruitenberg EJ
Tijdschr Diergeneeskd; 1990 Apr; 115(8):362-70. PubMed ID: 2186504
[TBL] [Abstract][Full Text] [Related]
2. [The future of vaccines: recombinant DNA vaccines].
van Dam RH; Keus RJ
Tijdschr Diergeneeskd; 1990 May; 115(9):413-9. PubMed ID: 2188394
[TBL] [Abstract][Full Text] [Related]
3. [Eradication of smallpox. The first great progress of vaccination immunology].
Skinhøj P
Ugeskr Laeger; 2000 Jan; 162(1):36-7. PubMed ID: 10658490
[No Abstract] [Full Text] [Related]
4. New developments in vaccine research--unveiling the secret of vaccine adjuvants.
de Veer M; Meeusen E
Discov Med; 2011 Sep; 12(64):195-204. PubMed ID: 21955847
[TBL] [Abstract][Full Text] [Related]
5. [Improvement of veterinary vaccines through the use of new adjuvants].
Hilgers LA
Tijdschr Diergeneeskd; 1991 May; 116(10):508-12. PubMed ID: 2048061
[TBL] [Abstract][Full Text] [Related]
6. Vaccinology in practical perspective.
Hilleman MR
Dev Biol Stand; 1986; 63():5-13. PubMed ID: 3527820
[TBL] [Abstract][Full Text] [Related]
7. [Historical review of smallpox, the eradication of smallpox and the attenuated smallpox MVA vaccine].
Mayr A
Berl Munch Tierarztl Wochenschr; 1999 Sep; 112(9):322-8. PubMed ID: 10507180
[TBL] [Abstract][Full Text] [Related]
8. [New vaccination strategies].
Plotkin SA
Bull Acad Natl Med; 2008 Mar; 192(3):511-8; discussion 518-9. PubMed ID: 18819697
[TBL] [Abstract][Full Text] [Related]
9. Recombinant DNA technology for producing new rinderpest virus vaccines.
Barrett T
Expert Rev Vaccines; 2005 Feb; 4(1):113-20. PubMed ID: 15757478
[TBL] [Abstract][Full Text] [Related]
10. [The vaccine metaphor. From inoculation to vaccination].
Moulin AM
Hist Philos Life Sci; 1992; 14(2):271-97. PubMed ID: 1342727
[TBL] [Abstract][Full Text] [Related]
11. [The meaning of vaccine or when predicting is a duty].
Bahia Lopes M
Hist Cienc Saude Manguinhos; 1996; 3(1):65-79. PubMed ID: 11625246
[TBL] [Abstract][Full Text] [Related]
12. Mass vaccination programs in developing countries.
Foege WH; Eddins DL
Prog Med Virol; 1973; 15():205-43. PubMed ID: 4572438
[TBL] [Abstract][Full Text] [Related]
13. [On three revolutions of vaccine].
Kou Y
Zhonghua Yi Shi Za Zhi; 2006 Apr; 36(2):104-8. PubMed ID: 17096989
[TBL] [Abstract][Full Text] [Related]
14. Cytokine adjuvants for vaccine therapy of neoplastic and infectious disease.
Decker WK; Safdar A
Cytokine Growth Factor Rev; 2011 Aug; 22(4):177-87. PubMed ID: 21862380
[TBL] [Abstract][Full Text] [Related]
15. Vaccines in historic evolution and perspective: a narrative of vaccine discoveries.
Hilleman MR
J Hum Virol; 2000; 3(2):63-76. PubMed ID: 10850891
[TBL] [Abstract][Full Text] [Related]
16. [Vaccination: principles and practice in 1980. Review and concepts. I. Historical development, adverse effects, diphtheria, tetanus, and whooping cough, poliomyelitis, and measles].
Ramírez Ronda CH; Bermúdez RH; Pérez Pabón MJ; Quiñones-Soto RA
Bol Asoc Med P R; 1980 Jul; 72(7):339-52. PubMed ID: 7000091
[No Abstract] [Full Text] [Related]
17. [Not Available].
Henig EM
Quellen Stud Gesch Pharm; 1997; 73():1-284. PubMed ID: 11636640
[No Abstract] [Full Text] [Related]
18. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
19. New technologies for vaccines.
Dorner F; Eibl J; Barrett PN
Wien Klin Wochenschr; 1999 Mar; 111(5):199-206. PubMed ID: 10226350
[TBL] [Abstract][Full Text] [Related]
20. [Antiviral vaccines].
Girard M
Med Trop (Mars); 1999; 59(4 Pt 2):522-6. PubMed ID: 10901858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
